In addition to promoting tumour cell survival, Bcl-XL can also boost metastasis and EMT of pancreatic neuroendocrine tumour cells via epigenetically enhancing TGFβ signalling (Choi et al., 2016). The gene discussed is BCL2L1; the disease is neoplasm.